Nrf2 activation initiates phase II enzymes expressions, such as heme oxygenase-1 (HO-1) and NADPH quinone oxidoreductase 1 (NQO1), which mitigates the pathogenesis of neurodegenerative diseases [7]. This evidence concerns the gene NFE2L2 and neurodegenerative disease.